Expression of FTL in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

FTL is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 5111.6

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

7252.4

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	32517.2
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	24514.5
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	23938.9
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	19670.4
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	16168.1
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	14813.2
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	14484.1
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	13890.2
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	13266.2
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	12395.1
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	12231.8
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	12087.5
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	11825.0
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	11734.6
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	11415.2
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	11300.9
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	11142.6
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	10758.3
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	10700.3
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	10508.0
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	10241.6
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	10183.0
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	10144.1
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	10046.2
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	9992.7
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	9881.2
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	9843.3
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	9611.1
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	9611.0
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	9478.2
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	9291.5
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	9257.3
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	9239.5
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	9088.9
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	8967.0
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	8956.4
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	8745.8
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	8734.1
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	8716.5
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	8646.8
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	8521.2
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	8493.2
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	8367.6
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	8360.7
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	8337.8
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	8290.1
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	8220.2
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	8171.8
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	8093.3
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	8065.8
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	7876.4
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	7815.8
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	7632.2
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	7583.2
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	7497.0
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	7387.0
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	7260.2
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	7170.0
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	7096.0
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	7013.6
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	6997.4
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	6947.7
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	6734.4
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	6661.3
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	6602.6
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	6595.6
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	6573.1
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	6554.4
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	6550.2
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	6507.9
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	6496.8
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	6491.0
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	6315.4
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	6303.8
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	6204.8
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	6191.8
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	6058.6
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	6055.0
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	5955.6
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	5895.4
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	5816.7
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	5714.0
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	5702.3
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	5682.1
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	5639.4
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	5639.0
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	5493.6
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	5419.7
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	5419.0
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	5294.8
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	5146.1
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	5077.1
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	5076.5
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	5057.1
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	5042.4
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	5025.8
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	4978.0
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	4942.2
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	4902.9
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	4872.2
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	4845.9
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	4781.5
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	4632.3
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	4563.7
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	4470.1
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	4417.0
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	4408.3
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	4370.8
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	4340.6
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	4318.4
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	4170.7
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	4158.9
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	4009.8
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	3870.1
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	3866.7
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	3852.4
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	3845.7
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	3837.0
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	3755.1
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	3702.3
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	3669.6
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	3607.0
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	3281.9
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	3236.6
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	3173.5
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	3132.9
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	3112.2
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	3053.6
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	3008.4
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	2949.0
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	2887.2
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	2728.2
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	2632.3
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	2546.3
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	2501.1
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	2461.6
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	2315.3
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	2255.1
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	2046.3
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	1972.9
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	1886.9
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

FTL is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 10799.6

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

7698.6

Number of samples

Samples

Sample	Description	pTPM
AK188	N, NA, stage:NA, alive, 420 days	40834.0
AK005	N, NA, stage:NA, dead, 240 days	19330.8
AK153	N, NA, stage:NA, dead, 240 days	18301.6
AK236	N, NA, stage:NA, dead, 360 days	16353.7
AK185	N, NA, stage:NA, alive, 330 days	16003.4
AK030	N, NA, stage:NA, dead, 120 days	14282.5
AK072	N, NA, stage:NA, dead, 150 days	12358.1
AK051	N, NA, stage:NA, dead, 360 days	12332.7
AK183	N, NA, stage:NA, alive, 360 days	11758.7
AK091	N, NA, stage:NA, dead, 210 days	11643.6
AK055	N, NA, stage:NA, dead, 240 days	11290.3
AK167	N, NA, stage:NA, dead, 180 days	11109.9
AK218	N, NA, stage:NA, dead, 180 days	11016.8
AK003	N, NA, stage:NA, dead, 600 days	10582.3
AK085	N, NA, stage:NA, alive, 660 days	9881.5
AK178	N, NA, stage:NA, dead, 240 days	9554.3
AK076	N, NA, stage:NA, alive, 660 days	9161.3
AK139	N, NA, stage:NA, dead, 270 days	8307.4
AK133	N, NA, stage:NA, dead, 360 days	8030.0
AK149	N, NA, stage:NA, dead, 420 days	7886.9
AK049	N, NA, stage:NA, dead, 180 days	7612.2
AK134	N, NA, stage:NA, dead, 360 days	7153.1
AK231	N, NA, stage:NA, dead, 240 days	7103.3
AK165	N, NA, stage:NA, alive, 360 days	6794.8
AK068	N, NA, stage:NA, alive, 360 days	6702.2
AK195	N, NA, stage:NA, dead, 390 days	6682.9
AK216	N, NA, stage:NA, dead, 360 days	6628.6
AK117	N, NA, stage:NA, dead, 210 days	6372.1
AK079	N, NA, stage:NA, dead, 210 days	6218.7
AK006	N, NA, stage:NA, dead, 360 days	6044.2
AK199	N, NA, stage:NA, alive, 1860 days	5715.6
AK158	N, NA, stage:NA, dead, 360 days	5651.7
AK227	N, NA, stage:NA, alive, 300 days	5424.4
AK103	N, NA, stage:NA, alive, 1320 days	5348.8
AK205	N, NA, stage:NA, dead, 120 days	5298.0
AK156	N, NA, stage:NA, dead, 330 days	5035.4
AK071	N, NA, stage:NA, dead, 540 days	4893.1
AK142	N, NA, stage:NA, alive, 90 days	4408.9
AK015	N, NA, stage:NA, alive, 720 days	4290.5
AK043	N, NA, stage:NA, alive, 660 days	4179.1
AK074	N, NA, stage:NA, alive, 300 days	4177.8
AK053	N, NA, stage:NA, dead, 300 days	4175.7
AK124	N, NA, stage:NA, alive, 1920 days	4090.2
AK173	N, NA, stage:NA, dead, 180 days	3983.4
AK098	N, NA, stage:NA, dead, 660 days	3972.7
AK089	N, NA, stage:NA, dead, 330 days	3686.6
AK100	N, NA, stage:NA, alive, 960 days	3595.2
AK066	N, NA, stage:NA, alive, 960 days	3568.5
AK099	N, NA, stage:NA, dead, 420 days	3539.7
AK081	N, NA, stage:NA, dead, 180 days	3518.6
AK213	N, NA, stage:NA, alive, 2010 days	3461.9
AK088	N, NA, stage:NA, dead, 360 days	3249.1
AK041	N, NA, stage:NA, alive, 810 days	3216.0
AK123	N, NA, stage:NA, dead, 180 days	2515.7
AK226	N, NA, stage:NA, dead, 360 days	2348.2
AK035	N, NA, stage:NA, dead, 210 days	2201.0
AK102	N, NA, stage:NA, alive, 1740 days	1915.2
AK002	N, NA, stage:NA, dead, 570 days	1729.4
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0167530003	Tumor	2.7
CPT0087730003	Tumor	2.6
CPT0186100003	Tumor	2.4
CPT0206670004	Tumor	2.0
CPT0189650004	Tumor	1.9
CPT0205890003	Tumor	1.8
CPT0127420003	Tumor	1.6
CPT0064650003	Tumor	1.6
CPT0228220003	Tumor	1.6
CPT0209440003	Tumor	1.4
CPT0206450003	Tumor	1.2
CPT0079790003	Tumor	1.1
CPT0162020003	Tumor	1.1
CPT0216920008	Tumor	1.0
CPT0207090003	Tumor	0.9
CPT0089150003	Tumor	0.9
CPT0093550003	Tumor	0.9
CPT0218670003	Tumor	0.9
CPT0189460003	Tumor	0.7
CPT0221180003	Tumor	0.6
CPT0167970003	Tumor	0.4
CPT0092440003	Tumor	0.4
CPT0206880003	Tumor	0.3
CPT0168480003	Tumor	0.3
CPT0208980003	Tumor	0.3
CPT0218960004	Tumor	0.2
CPT0217430008	Tumor	0.2
CPT0217000004	Tumor	0.2
CPT0205570003	Tumor	0.2
CPT0196850003	Tumor	0.1
CPT0125510003	Tumor	0.1
CPT0204350003	Normal	0.1
CPT0218690004	Tumor	0.1
CPT0161730003	Tumor	0.1
CPT0167640003	Tumor	0.1
CPT0104220003	Tumor	0.0
CPT0125570003	Tumor	0.0
CPT0190360004	Tumor	0.0
CPT0206330003	Tumor	0.0
CPT0162100003	Tumor	0.0
CPT0087570003	Tumor	0.0
CPT0168830003	Tumor	-0.1
CPT0206780003	Tumor	-0.1
CPT0189750004	Tumor	-0.1
CPT0217060003	Tumor	-0.1
CPT0204390003	Normal	-0.2
CPT0204380003	Normal	-0.2
CPT0205450004	Tumor	-0.2
CPT0182500003	Tumor	-0.3
CPT0204360003	Normal	-0.3
CPT0225760003	Tumor	-0.3
CPT0206000004	Tumor	-0.3
CPT0168590003	Tumor	-0.3
CPT0189250003	Tumor	-0.3
CPT0093360003	Tumor	-0.4
CPT0168380003	Tumor	-0.5
CPT0219080004	Tumor	-0.5
CPT0168720003	Tumor	-0.5
CPT0087950003	Tumor	-0.5
CPT0204370003	Normal	-0.5
CPT0204410003	Normal	-0.5
CPT0175060003	Tumor	-0.5
CPT0087680003	Tumor	-0.5
CPT0093510003	Tumor	-0.5
CPT0224600003	Tumor	-0.5
CPT0071100003	Tumor	-0.5
CPT0204420003	Normal	-0.6
CPT0204330003	Normal	-0.6
CPT0206560003	Tumor	-0.6
CPT0171580008	Tumor	-0.6
CPT0217880003	Tumor	-0.6
CPT0224540004	Tumor	-0.6
CPT0224330003	Tumor	-0.6
CPT0123530003	Tumor	-0.6
CPT0204400003	Normal	-0.6
CPT0064890003	Tumor	-0.6
CPT0206110003	Tumor	-0.7
CPT0168080003	Tumor	-0.7
CPT0182550003	Tumor	-0.7
CPT0189850004	Tumor	-0.7
CPT0218330004	Tumor	-0.7
CPT0127480003	Tumor	-0.8
CPT0199770003	Tumor	-0.8
CPT0093450003	Tumor	-0.8
CPT0125220003	Tumor	-0.8
CPT0205670004	Tumor	-0.8
CPT0218830004	Tumor	-0.8
CPT0217100003	Tumor	-0.9
CPT0201710003	Tumor	-0.9
CPT0204340003	Normal	-0.9
CPT0190240004	Tumor	-0.9
CPT0167860004	Tumor	-1.0
CPT0205780003	Tumor	-1.0
CPT0167750004	Tumor	-1.0
CPT0207030003	Tumor	-1.0
CPT0168270003	Tumor	-1.1
CPT0093590003	Tumor	-1.1
CPT0218890004	Tumor	-1.1
CPT0182580003	Tumor	-1.1
CPT0104330003	Tumor	-1.3
CPT0162140003	Tumor	-1.4
CPT0002410011	Tumor	-1.4
CPT0218770003	Tumor	-1.4
CPT0217190003	Tumor	-1.5
CPT0206230003	Tumor	-1.5
CPT0225730003	Tumor	-1.6
CPT0078580003	Tumor	-1.7
CPT0224390004	Tumor	-1.8
CPT0217710008	Tumor	-2.2
CPT0189570004	Tumor	-2.2
Show allShow less

GLIOMA - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA041602	Antibody CAB020769
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Glioma, malignant, High grade
Glioma, malignant, Low grade